Fresenius Medical Care

Fresenius Medical Care

Financials

2022 Annual Revenue
€19.40 Billion

2022 Annual Gross Profit
€5.31 Billion

2022 Annual Net Income
€895 Million

2022 Annula Revenue Growth 
10.10%

2022 Number of Employees
4,116

Credit Rating

Moody's Rated: Investment Grade Baa3 (Long-Term)

Fresenius Medical Care

Fresenius Medical Care

Fresenius Medical Care (NYSE: FMS) provides dialysis related products, inpatient/outpatient care products, and services such as engineering to hospitals and related facilities. Fresenius operates 4,116 dialysis centers in North America and has over 128,000 employees. These facilities routinely provide medically necessary renal care to hundreds of thousands of patients with chronic kidney failure.